These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 21373789

  • 1. Effects of morphine on pain-elicited and pain-suppressed behavior in CB1 knockout and wildtype mice.
    Miller LL, Picker MJ, Schmidt KT, Dykstra LA.
    Psychopharmacology (Berl); 2011 Jun; 215(3):455-65. PubMed ID: 21373789
    [Abstract] [Full Text] [Related]

  • 2. Effects of alterations in cannabinoid signaling, alone and in combination with morphine, on pain-elicited and pain-suppressed behavior in mice.
    Miller LL, Picker MJ, Umberger MD, Schmidt KT, Dykstra LA.
    J Pharmacol Exp Ther; 2012 Jul; 342(1):177-87. PubMed ID: 22514333
    [Abstract] [Full Text] [Related]

  • 3. Constitutive activity at the cannabinoid CB1 receptor is required for behavioral response to noxious chemical stimulation of TRPV1: antinociceptive actions of CB1 inverse agonists.
    Fioravanti B, De Felice M, Stucky CL, Medler KA, Luo MC, Gardell LR, Ibrahim M, Malan TP, Yamamura HI, Ossipov MH, King T, Lai J, Porreca F, Vanderah TW.
    J Neurosci; 2008 Nov 05; 28(45):11593-602. PubMed ID: 18987195
    [Abstract] [Full Text] [Related]

  • 4. Behavioral effects of morphine and cocaine in M1 muscarinic acetylcholine receptor-deficient mice.
    Carrigan KA, Dykstra LA.
    Psychopharmacology (Berl); 2007 May 05; 191(4):985-93. PubMed ID: 17211651
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Attenuation of morphine antinociceptive tolerance by cannabinoid CB1 and CB2 receptor antagonists.
    Altun A, Yildirim K, Ozdemir E, Bagcivan I, Gursoy S, Durmus N.
    J Physiol Sci; 2015 Sep 05; 65(5):407-15. PubMed ID: 25894754
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. AM-251 and rimonabant act as direct antagonists at mu-opioid receptors: implications for opioid/cannabinoid interaction studies.
    Seely KA, Brents LK, Franks LN, Rajasekaran M, Zimmerman SM, Fantegrossi WE, Prather PL.
    Neuropharmacology; 2012 Oct 05; 63(5):905-15. PubMed ID: 22771770
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The endocannabinoid hydrolysis inhibitor SA-57: Intrinsic antinociceptive effects, augmented morphine-induced antinociception, and attenuated heroin seeking behavior in mice.
    Wilkerson JL, Ghosh S, Mustafa M, Abdullah RA, Niphakis MJ, Cabrera R, Maldonado RL, Cravatt BF, Lichtman AH.
    Neuropharmacology; 2017 Mar 01; 114():156-167. PubMed ID: 27890602
    [Abstract] [Full Text] [Related]

  • 15. Mu-opioid and CB1 cannabinoid receptors of the dorsal periaqueductal gray interplay in the regulation of fear response, but not antinociception.
    Godoi MM, Junior HZ, da Cunha JM, Zanoveli JM.
    Pharmacol Biochem Behav; 2020 Jul 01; 194():172938. PubMed ID: 32376258
    [Abstract] [Full Text] [Related]

  • 16. The role of CB1 receptors in sweet versus fat reinforcement: effect of CB1 receptor deletion, CB1 receptor antagonism (SR141716A) and CB1 receptor agonism (CP-55940).
    Ward SJ, Dykstra LA.
    Behav Pharmacol; 2005 Sep 01; 16(5-6):381-8. PubMed ID: 16148442
    [Abstract] [Full Text] [Related]

  • 17. Low dosage of rimonabant leads to anxiolytic-like behavior via inhibiting expression levels and G-protein activity of kappa opioid receptors in a cannabinoid receptor independent manner.
    Zádor F, Lénárt N, Csibrány B, Sántha M, Molnár M, Tuka B, Samavati R, Klivényi P, Vécsei L, Marton A, Vizler C, Nagy GM, Borsodi A, Benyhe S, Páldy E.
    Neuropharmacology; 2015 Feb 01; 89():298-307. PubMed ID: 25446673
    [Abstract] [Full Text] [Related]

  • 18. Bladder function in a cannabinoid receptor type 1 knockout mouse.
    Füllhase C, Campeau L, Sibaev A, Storr M, Hennenberg M, Gratzke C, Stief C, Hedlund P, Andersson KE.
    BJU Int; 2014 Jan 01; 113(1):144-51. PubMed ID: 24053792
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Antinociceptive effects of the non-selective cannabinoid receptor agonist CP 55,940 are absent in CB1(-/-) and not CB2(-/-) mice in models of acute and persistent pain.
    Sain NM, Liang A, Kane SA, Urban MO.
    Neuropharmacology; 2009 Sep 01; 57(3):235-41. PubMed ID: 19538975
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.